Abstract Details
|
Holly Elser, MD, PhD
(Hospital of the University of Pennsylvania)
PRESENTER |
Dr. Elser has nothing to disclose. |
| Rogan Magee, MD, PhD (Penn Medicine) | Dr. Magee has nothing to disclose. |
| Sabrina Abbruzzese | Ms. Abbruzzese has nothing to disclose. |
| Danielle Sandsmark, MD | The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense. |
| Rebecca F. Gottesman, MD, PhD (Johns Hopkins University) | The institution of Dr. Gottesman has received research support from NIH. |
| Tom Mosley, PhD | Dr. Mosley has nothing to disclose. |
| David A. Wolk, MD, FAAN (University of Pennsylvania) | Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly. |
| Andrea L. Schneider, MD, PhD (University of Pennsylvania) | Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology. |